Best-in-Class Molecular Testing
Eurofins Genomics provides best-in-class molecular testing for clinical samples. Quality and documentation control is backed by the highest levels of clinical accreditation-CAP and CLIA. Due to our logistical position, our clinical laboratory can provide extremely fast turn-around-time on testing from anywhere in the US.
Services include, but are not limited to:
- Clinical trials
- Sanger sequencing: design and validation of Sanger sequencing assays for SNPs and small insertion or deletion variants
- Microsatellite: design and validation of fragment size and microsatellite assays
- qPCR Testing
- RT-PCR Testing
- Next generation sequencing cystic fibrosis mutation panel
- Customized patient reports
Sample Collection: Extraction can be performed from a variety of collection methods including DNA extraction from whole blood, buccal swabs and saliva.
Credentials: CLIA, CAP; New York, California, Pennsylvania, and Maryland.
Contact us to discuss your project: COVIDtest@eurofins.com
Mailing Address for Samples
ATTN: Applied Genomics
12701 Plantside Dr.
Louisville, KY 40299
Additional Clinical Services from Eurofins Group
The Eurofins Group contains multiple clinical laboratories in the United States and globally. Each lab offers expertise in different areas. If Eurofins Genomics cannot meet the needs of your project, there is a high likelihood that one of our labs within Eurofins does.
A shared ambition: to offer all our patients the best possible care
Clinical diagnostics at the heart of the healthcare system
Clinical diagnostic tests are a key factor in 70% of medical decisions.
A central element in healthcare, clinical diagnostic testing today contributes to every stage of patient care: predisposition testing, prevention, diagnostics, theranostics and monitoring of treatments.
Innovating today for the health of all tomorrow
Eurofins stands for a conception of clinical diagnostics entirely focused on excellence, innovation and technological investment.
Genetics and genomics are gradually marking out the new outlines of tomorrow's clinical diagnostics and our labs are investing heavily in these advanced technologies (NGS, i.e. Next Generation Sequencing), which already have a large number of applications for many people from NIPT (Non Invasive Prenatal Testing) to predictive genetics of cancers or in personalized medicine that can offer patients individualized treatment based on their genetic and metabolic profiles.
The commitment of our laboratories: to work for public health
A healthcare service available to all
With tens of thousands of clinical diagnostic tests every day, the laboratories of the Clinical Diagnostics division strive to ensure that every patient, wherever he or she lives, is assured of access to the most specialized and most innovative techniques for diagnosis, monitoring and therapeutic adjustment.
With our logistics expertise and our daily sample collection and delivery network, we can guarantee perfect continuity in the provision of care, the same quality and the same access to innovation across all the regions that we serve, to the benefit of patients and the medical profession.
Our labs, technical platforms and our high specialized clinical testing platforms are thus working in the service of public health, focusing on improving the quality and effectiveness of clinical diagnostics and giving all our partners access to state-of-the-art clinical biology, the biology of today and tomorrow in the service of a more personalized medicine.
Enabling equal access to the most innovative tests
Offering the most innovative tests to the wider population at a cost that is affordable for society, this is our mission.
While promoting prevention and screening, earlier and more accurate diagnoses, more efficient, faster and safer therapeutic management, and at the same time reducing diagnostic and therapeutic error and side effects of treatments, our laboratories also respond to the need to control health spending.
We therefore work closely with health authorities, clinical pathology professionals and clinicians as well as with public and private hospitals to monitor developments in medicine and to reflect on the positioning, financing and innovation in clinical biology in the service of public health.
Learn more by visiting Eurofins Clinical Diagnostics.